GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seelos Therapeutics Inc (STU:NXE) » Definitions » Policy Acquisition Expense

Seelos Therapeutics (STU:NXE) Policy Acquisition Expense


View and export this data going back to 2010. Start your Free Trial

What is Seelos Therapeutics Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Seelos Therapeutics (STU:NXE) Business Description

Traded in Other Exchanges
Address
300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.